Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta- and alpha-cell dysfunction in type 2 diabetes.

S Del Prato1, P Marchetti

  • 1Department of Endocrinology and Metabolism, Section of Diabetes, University of Pisa, Pisa 56124, Italy. delprato@immr.med.unipi.it

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|January 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of the molecular tumor board: learnings from the ROME trial.

NPJ precision oncology·2026
Same author

Asthma incidence can be influenced by climate change in Italy: findings from the GEIRD study-a climatological and epidemiological assessment.

Scientific reports·2023
Same author

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7 1506-1514, 2007.

Clinical journal of the American Society of Nephrology : CJASN·2023
Same author

Breakthrough pain in patients with multiple myeloma: a secondary analysis of IOPS MS study.

European review for medical and pharmacological sciences·2023
Same author

Clinical Predictors of Response to Anti-PD-1 First-Line Treatment in a Single-Centre Patient Cohort: A Real-World Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.

Breast cancer research and treatment·2021
Same journal

Determinants of Infant Participation and Non-Participation in Primary Prevention Trials.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Same journal

Inflammatory Profile of Lipedema: A Comparative Evaluation with Obese and Normal-weight Women.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Same journal

Comparative Effects of Experimental Diabetes Mellitus and Glucocorticoid-Induced Hypercortisolemia on Pancreatic and Adrenal Endocrine Architecture: A Pathological Study in Rats.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Same journal

Psychiatric Symptoms in Women with Mild Autonomous Cortisol Secretion Versus Non-Functioning Adrenal Adenomas: A Cross-Sectional Study.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Same journal

Antisemitism as a Chronic Cardiometabolic, Endocrine, and Glutamatergic Stressor Requiring Psychometric Monitoring.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Same journal

Severe Acute Respiratory Syndrome Coronavirus-2 Infection and New Changes in Thyroid Function Parameters during Hospitalization and Follow-up.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
See all related articles

Type 2 diabetes involves insulin resistance and impaired insulin secretion from beta-cells. Addressing beta- and alpha-cell dysfunction is a promising therapeutic strategy for managing hyperglycemia.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Pathophysiology

Background:

  • Insulin resistance is a key feature of type 2 diabetes (T2D).
  • Hyperglycemia in T2D arises from both insulin resistance and impaired insulin secretion.
  • Beta-cell dysfunction, including functional and survival defects, underlies reduced insulin secretion.

Purpose of the Study:

  • To elucidate the pathogenetic mechanisms of type 2 diabetes, focusing on beta-cell dysfunction.
  • To examine the role of impaired insulin and glucagon secretion in hyperglycemia.
  • To highlight the therapeutic potential of targeting pancreatic islet cell dysfunction.

Main Methods:

  • Analysis of beta-cell function, including insulin secretion pulsatility and first-phase release.

Related Experiment Videos

  • Assessment of beta-cell mass reduction at diagnosis.
  • Evaluation of pancreatic alpha- and beta-cell hormone secretion patterns (insulin, glucagon) and their ratio.

    • Main Results:

    • Early functional defects in beta-cells include abnormal insulin secretion pulsatility and loss of first-phase insulin release.
    • Significant reduction in beta-cell mass is observed at T2D diagnosis.
    • Impaired glucagon suppression and altered insulin:glucagon molar ratio contribute to hyperglycemia.

    Conclusions:

    • Progressive beta-cell dysfunction (function and mass) drives the natural history of T2D.
    • Chronic hyperglycemia and elevated free fatty acids may exacerbate beta-cell defects.
    • Targeting both beta- and alpha-cell dysfunction presents a rational therapeutic approach for T2D.